Akathisia: a review and case report following paroxetine treatment.
Although akathisia is most commonly associated with neuroleptic medication, few cases of paroxetine-induced akathisia have been reported. A review of the authors' charts (C.F.B., A.N., S.N.G., and G.S.S.) was conducted to determine an estimated incidence for paroxetine-induced akathisia. Three cases of akathisia were reported in 67 patients treated with paroxetine. A case of akathisia secondary to paroxetine in an 18-year-old female is presented. Given the potential untoward effects of this syndrome, early diagnosis is essential. Clinical presentations and differential diagnoses are discussed.
Baldassano
C F
CF
Psychopharmacology Clinic, Massachusetts General Hospital, Boston 02114, USA.
Truman
C J
CJ
Nierenberg
A
A
Ghaemi
S N
SN
Sachs
G S
GS
D000293:Adolescent; D017109:Akathisia, Drug-Induced / Q000188:drug therapy / Q000209:etiology*; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D009460:Neurologic Examination / Q000187:drug effects; D017374:Paroxetine / Q000009:adverse effects* / Q000627:therapeutic use; D011433:Propranolol / Q000008:administration & dosage
D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine; D011433:Propranolol